Synageva BioPharma Corp.
Founded 1996
Lexington, United States
20 employees
Post Ipo Equity
Total: $597.40M
Biotechnology, Health and Wellness +1
Lexington, United States
20 employees
Post Ipo Equity
Total: $597.40M
Biotechnology, Health and Wellness +1
General Information
Get notified when Synageva BioPharma Corp. moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Synageva BioPharma Corp.
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
United States Market
Biotechnology
About Synageva BioPharma Corp.
Funding Rounds & Investors (11)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Post-IPO Equity | •••••• | - | 05 Jan 2015 | |
| Post-IPO Equity | •••••• | - | 30 Sep 2013 | |
| Post-IPO Equity | •••••• | - | 05 Jan 2012 | |
| Venture Round | •••••• | 4 |
|
21 Mar 2011 |
| Series F | •••••• | - | 02 Aug 2010 |
Synageva BioPharma Corp. Alternatives & Competitors
Synageva BioPharma Corp. vs
Ultragenyx
United States
Going Beyond Every Day
Post Ipo Equity
1535 employees
Biotechnology, Health Care
Synageva BioPharma Corp. vs
Optum Frontier Therapies has introduced an innovative care model that simplifies the process for pat...
Health Care, Pharmaceutical
Synageva BioPharma Corp. vs
Ultragenyx is a biopharmaceutical company focused on developing therapies for rare and very rare dis...
FAQ About Synageva BioPharma Corp.
Synageva BioPharma is a biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines for people living with rare diseases of high unmet medical need. We are passionate about our commitment to improving their lives and those of their families for generations to...
Synageva BioPharma Corp. was founded in 1996.
Synageva BioPharma Corp. is headquartered in Lexington, United States.
Synageva BioPharma Corp. operates in the following industries: Biotechnology, Health and Wellness, Pharmaceutical.
Synageva BioPharma Corp. has approximately 20 employees.
Synageva BioPharma Corp. has completed 11 funding rounds, raising a total of $597.40M. The latest funding stage is Post Ipo Equity.
Top alternatives and competitors to Synageva BioPharma Corp. include Ultragenyx, Optum Frontier Therapies, Ultragenyx Pharmaceutical Inc., Orpha Biotech Srl, Coave Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Synageva BioPharma Corp. and Ultragenyx are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Don't just browse. Track.
Signal Tracker monitors Synageva BioPharma Corp. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.